Cisplatin is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Accord Healthcare, Inc.. The primary component is Cisplatin.
Product ID | 16729-288_43a22af4-12fc-640e-e054-00144ff88e88 |
NDC | 16729-288 |
Product Type | Human Prescription Drug |
Proprietary Name | Cisplatin |
Generic Name | Cisplatin |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2016-12-13 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA206774 |
Labeler Name | Accord Healthcare, Inc. |
Substance Name | CISPLATIN |
Active Ingredient Strength | 1 mg/mL |
Pharm Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [EXT] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2016-12-13 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA206774 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2016-12-13 |
Marketing Category | ANDA |
Application Number | ANDA206774 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2016-12-13 |
Ingredient | Strength |
---|---|
CISPLATIN | 1 mg/mL |
SPL SET ID: | b2b029f5-0d7e-4e7f-accc-b722aec34c68 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9504 | CISplatin | Cisplatin |
0143-9505 | CISplatin | Cisplatin |
0703-5747 | Cisplatin | Cisplatin |
0703-5748 | Cisplatin | Cisplatin |
16729-288 | Cisplatin | Cisplatin |
44567-509 | CISplatin | CISplatin |
44567-510 | CISplatin | CISplatin |
44567-511 | CISplatin | CISplatin |
44567-530 | Cisplatin | cisplatin |
47781-609 | Cisplatin | cisplatin |
47781-610 | Cisplatin | cisplatin |
63323-103 | Cisplatin | CISPLATIN |
68001-283 | Cisplatin | Cisplatin |
68083-162 | CISPLATIN | Cisplatin |
68083-163 | CISPLATIN | Cisplatin |
70860-206 | Cisplatin | cisplatin |
61126-003 | Platinol | cisplatin |
61126-004 | Platinol-AQ | cisplatin |